CN103585266B - Patchouli compound essential oil - Google Patents
Patchouli compound essential oil Download PDFInfo
- Publication number
- CN103585266B CN103585266B CN201310552538.9A CN201310552538A CN103585266B CN 103585266 B CN103585266 B CN 103585266B CN 201310552538 A CN201310552538 A CN 201310552538A CN 103585266 B CN103585266 B CN 103585266B
- Authority
- CN
- China
- Prior art keywords
- patchouli
- oil
- essential oil
- compound essential
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000341 volatile oil Substances 0.000 title claims abstract description 23
- 150000001875 compounds Chemical class 0.000 title claims abstract description 18
- 240000002505 Pogostemon cablin Species 0.000 title claims abstract description 16
- 235000011751 Pogostemon cablin Nutrition 0.000 title claims abstract description 16
- 235000004433 Simmondsia californica Nutrition 0.000 claims abstract description 10
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 8
- 239000001738 pogostemon cablin oil Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 241000221096 Simmondsia chinensis Species 0.000 claims abstract 2
- PEYUIKBAABKQKQ-AFHBHXEDSA-N (+)-sesamin Chemical compound C1=C2OCOC2=CC([C@H]2OC[C@H]3[C@@H]2CO[C@@H]3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-AFHBHXEDSA-N 0.000 claims description 8
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 claims description 8
- PEYUIKBAABKQKQ-UHFFFAOYSA-N epiasarinin Natural products C1=C2OCOC2=CC(C2OCC3C2COC3C2=CC=C3OCOC3=C2)=C1 PEYUIKBAABKQKQ-UHFFFAOYSA-N 0.000 claims description 7
- 229960003255 natamycin Drugs 0.000 claims description 7
- VRMHCMWQHAXTOR-CMOCDZPBSA-N sesamin Natural products C1=C2OCOC2=CC([C@@H]2OC[C@@]3(C)[C@H](C=4C=C5OCOC5=CC=4)OC[C@]32C)=C1 VRMHCMWQHAXTOR-CMOCDZPBSA-N 0.000 claims description 7
- 230000002421 anti-septic effect Effects 0.000 claims description 6
- 235000010298 natamycin Nutrition 0.000 claims description 6
- 239000004311 natamycin Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 8
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 206010020751 Hypersensitivity Diseases 0.000 abstract description 2
- 208000004880 Polyuria Diseases 0.000 abstract description 2
- 206010039509 Scab Diseases 0.000 abstract description 2
- 208000026935 allergic disease Diseases 0.000 abstract description 2
- 230000007815 allergy Effects 0.000 abstract description 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 2
- 230000019522 cellular metabolic process Effects 0.000 abstract description 2
- 239000011148 porous material Substances 0.000 abstract description 2
- 230000005808 skin problem Effects 0.000 abstract description 2
- 230000036560 skin regeneration Effects 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 208000020154 Acnes Diseases 0.000 abstract 1
- 230000004931 aggregating effect Effects 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
- 239000003921 oil Substances 0.000 description 21
- 235000019198 oils Nutrition 0.000 description 21
- 241000196324 Embryophyta Species 0.000 description 5
- 241000221095 Simmondsia Species 0.000 description 5
- 241000379194 Abies sibirica Species 0.000 description 4
- 241000191291 Abies alba Species 0.000 description 3
- 235000004507 Abies alba Nutrition 0.000 description 3
- 244000044822 Simmondsia californica Species 0.000 description 3
- 244000283070 Abies balsamea Species 0.000 description 2
- 235000007173 Abies balsamea Nutrition 0.000 description 2
- 241001311472 Abies sachalinensis Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- 230000035943 smell Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000004710 Abies lasiocarpa Nutrition 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 244000251953 Agaricus brunnescens Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- NCXMLFZGDNKEPB-UHFFFAOYSA-N Pimaricin Natural products OC1C(N)C(O)C(C)OC1OC1C=CC=CC=CC=CCC(C)OC(=O)C=CC2OC2CC(O)CC(O)(CC(O)C2C(O)=O)OC2C1 NCXMLFZGDNKEPB-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Abstract
The invention discloses patchouli compound essential oil. The patchouli compound essential oil comprises the following raw materials in parts by weight: 100 parts of patchouli oil, 10 to 30 parts of fir essential oil and 10 to 30 parts of simmondsia chinensis seed oil. The patchouli compound essential oil provided by the invention has antibacterial, anti-inflammation, sedative, detoxifying and diuretic effects, also has the effects of aggregating wound, promoting quick scabbing of the wound and promoting cell metabolism, is applicable to common skin, can promote skin regeneration, reduce inflammation phenomenon, minimize pores and tighten and moisture skin, has good curative effects on skin problems such as whelks, acnes and allergy, and particularly has the effects of curing rheumatism and relieving pain from rheumatism.
Description
Technical field
The present invention relates to a kind of quintessence oil, particularly relate to a kind of patchouli compound essential oil.
Background technology
Quintessence oil is a kind of aromatic substance, is generally the aromatic molecules extracted from plant, is the staple product of the industry such as perfume, flavouring agent, cosmetics, and the primary raw material of aromatotherapy.
Quintessence oil is prevalent in each position of plant, comprises the positions such as tree root, trunk, bark, tree stem, leaf and flower.But in fact it have more than be oil, be a kind of generate through photosynthesis organise and thing, be the fragrant plant race of complicated component.Important role is played the part of in the growth of quintessence oil to plant, except possessing and regulating temperature and prophylactic function, can also protective plant from the infringement of antibacterial and pathogenic bacteria.In addition, the quintessence oil in petal, can attract oneself useful insecticide close, also can avoid oneself harmful insecticide close, so people utilize this speciality of quintessence oil to expel insect and health of body in life simultaneously.
Ancient times, Herba Pogostemonis has medicinal history remote, specially separates snakebite insect bite.Its quintessence oil distills from tender leaf and obtains, and can control hair of scalp problem, and synergidae regenerates.Herba Pogostemonis quintessence oil distills from tender leaf and obtains, and before distillation, blade be allowed first dry and ferment.Have dense soil property taste, it is the quintessence oil that a kind of wine is the same, and time longer abnormal smells from the patient better.In champignon therapy, in compound essential Oil, drip Herba Pogostemonis quintessence oil, fragrance can be allowed more lasting.
Quintessence oil of more than two kinds mixes to reach specific therapeutical by compound essential Oil exactly, is mutually to coordinate between quintessence oil and quintessence oil, and some also has the effect of complementing each other, heightening the effect of a treatment each other.
Summary of the invention
A kind of patchouli compound essential oil, comprises following weight parts raw material: patchouli oil 100 parts, fir essential oil 10-30 part, Jojoba seed oil 10-30 part.
Preferably, described patchouli compound essential oil is made up of following weight parts raw material: patchouli oil 100 parts, fir essential oil 10-30 part, Jojoba seed oil 10-30 part, antiseptic 0.01-0.05 part.
By each raw material simple agitation mix homogeneously, described patchouli compound essential oil can be obtained.
Described antiseptic is sesamin and/or natamycin.Preferably, described antiseptic is 10-30 weight portion sesamin and 70-90 weight portion natamycin composition.
Patchouli oil, also known as: Herba Pogostemonis (POGOSTEMON CABLIN) oil, POGOSTEMON CABLIN OIL, No. CAS: 8014-09-3.
Described fir essential oil be selected from abies alba (ABIES ALBA) leaf oil, balsam fir (ABIESBALSAMEA) needle oil, pectination fir (ABIES PECTINATA) oil, Abies sibirica (ABIES SIBIRICA) oil and abies sachalinensis (ABIES SACHALINENSIS) leaf oil in one or its mixture.
Jojoba seed oil, also known as: Jojoba (SIMMONDSIA CHINENSIS) seed oil, SIMMONDSIA CHINENSIS (JOJOBA) SEED OIL, No. CAS: 61789-91-1.
Sesamin, English name: sesamin, No. CAS: 607-80-7.
Natamycin, English name: Pimaricin, No. CAS: 7681-93-8.
Patchouli compound essential oil of the present invention, there is anti-inflammation, calmness, removing toxic substances, diuresis, polymerization wound impel it to scab fast, promote the effect of cell metabolism, be applicable to general skin, can skin regeneration be promoted, dephlogistication phenomenon, convergence pore, compact Glycerin, has good curative effect, have the effect of curing rheumatism, link rheumatalgia especially to skin problems such as comedo, acne, allergy.
Detailed description of the invention
Embodiment 1-4
Take each raw material by table 1 corresponding data, be uniformly mixed, can patchouli compound essential oil be obtained.
Table 1: patchouli compound essential oil formula table unit: kilogram
| Embodiment 1 | Embodiment 2 | Embodiment 3 | Embodiment 4 | |
| Patchouli oil | 100 | 100 | 100 | 100 |
| Abies sibirica (ABIES SIBIRICA) oil | 20 | 20 | 20 | 20 |
| Jojoba seed oil | 20 | 20 | 20 | 20 |
| Sesamin | / | 0.03 | / | 0.006 |
| Natamycin | / | / | 0.03 | 0.024 |
Using method: after clean skin, patchouli compound essential oil is dropped in the palm of the hand, massages and extremely absorbs in face or health.
Test case
Respectively by the patchouli compound essential oil of embodiment 1-4, carry out fill with dark brown vial, open wide bottle cap, be placed in 35 DEG C, under relative humidity 85% environment, continuous observation, concrete outcome sees the following form.
Table 2: product stability test chart
| Phenomenon | |
| Embodiment 1 | 14th day, start to become sour; Before normal |
| Embodiment 2 | 22nd day, start to become sour; Before normal |
| Embodiment 3 | 28th day, start to become sour; Before normal |
| Embodiment 4 | 30th day, start to become sour; Before normal |
Become sour: product becomes sour, give out unhappy abnormal smells from the patient.Normal: product no abnormality seen, fragrance is pure.
As seen from the data in Table 2, add after antiseptic, can effectively extend the shelf life, special adopt sesamin and natamycin composite, Synergistic, substantially prolongs the shelf-life of product.
Another test, the compound essential Oil of embodiment 4, fill, in dark brown vial, is preserved at room temperature (18-25 DEG C) environment lower seal, phenomenon of not becoming sour in 3 years.
Claims (1)
1. a patchouli compound essential oil, is characterized in that, is made up of following weight parts raw material: patchouli oil 100 parts, fir essential oil 10-30 part, Jojoba seed oil 10-30 part, antiseptic 0.01-0.05 part;
Described antiseptic is 10-30 weight portion sesamin and 70-90 weight portion natamycin composition.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310552538.9A CN103585266B (en) | 2013-11-07 | 2013-11-07 | Patchouli compound essential oil |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310552538.9A CN103585266B (en) | 2013-11-07 | 2013-11-07 | Patchouli compound essential oil |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103585266A CN103585266A (en) | 2014-02-19 |
| CN103585266B true CN103585266B (en) | 2015-07-08 |
Family
ID=50075720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310552538.9A Expired - Fee Related CN103585266B (en) | 2013-11-07 | 2013-11-07 | Patchouli compound essential oil |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103585266B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104523473B (en) * | 2014-12-03 | 2017-11-28 | 广州市尚医生物科技有限公司 | A kind of anti-acne microemulsion system and preparation method thereof |
| CN105640803B (en) * | 2016-02-25 | 2018-10-30 | 刘忠波 | A kind of anti-dandruff, Anti-hair loss, hair products and preparation method thereof |
| CN107519048A (en) * | 2017-08-30 | 2017-12-29 | 广州市澳键丰泽生物科技股份有限公司 | A kind of compound plant heal-care essential oil and its preparation method and application |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101020861B (en) * | 2007-03-20 | 2010-04-14 | 天津郁美净集团有限公司 | Essence for daily use containing natural vegetable oils |
| CN103054989B (en) * | 2013-01-23 | 2014-07-16 | 云南伊纳姿生物科技有限公司 | Compound essential oil for preventing and treating psoriasis as well as preparation method thereof |
-
2013
- 2013-11-07 CN CN201310552538.9A patent/CN103585266B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103585266A (en) | 2014-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103585058B (en) | Lavender compound essential oil | |
| Nowak et al. | Clove oil—Properties and applications | |
| CN106266685A (en) | A kind of compound essential Oil and preparation method thereof | |
| CN106265147A (en) | A kind of floral water containing natural plant essential oils and preparation method thereof | |
| CN111714543A (en) | Herbal essential oil with sterilization effect and preparation method and application thereof | |
| CN103585266B (en) | Patchouli compound essential oil | |
| CN108078814A (en) | A kind of plant fragrance fluid composition with mosquito repellent function and its application in cosmetics | |
| KR20160004878A (en) | extracts of Chamaecyparis obutsa, method for preparing thereof, and composition comprising the same | |
| CN103585054B (en) | Sandalwood compound essential oil | |
| CN104323978A (en) | Compound essential oil for removing striae gravidarum | |
| KR100879051B1 (en) | Pharmaceutical composition for treating athlete's foot | |
| CN103585057B (en) | Mint compound essential oil | |
| CN103585056B (en) | Bergamot composite essential oil | |
| KR20140091920A (en) | A producing method for natural antimicrobial | |
| Subasree et al. | Essential oils in prevention of dental caries-An in-vitro study | |
| Omidpanah et al. | Antioxidant and antibacterial properties of the essential oils of two Iranian Medicinal Plants: Zhumeria majdae and Salvia mirzayanii | |
| CN111184674A (en) | Oral care agent for superficial wound care and application method thereof | |
| CN103585055B (en) | Compound cananga odorata essential oil | |
| CN101336966B (en) | Osmidrosis dispelling liniment containing natural essential oil of Zingiber corallinum Hance | |
| CN103585059B (en) | Chamomile compound essential oil | |
| CN103585060B (en) | Cedar compound essential oil | |
| CN103300078A (en) | Traditional Chinese medicine pesticide for vegetables | |
| Ghorbanzadeh et al. | A novel vaporizer to release volatile substances from aromatic plants | |
| CN111939215A (en) | Composition for treating bromhidrosis | |
| US20130052289A1 (en) | Medicine containing extracts of Ficus microcarpa for healing wounds of a diabetic patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Huang Chuhua Inventor before: Wang Feifen |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20170509 Address after: 523000 Guangdong city of Dongguan province Dongcheng District sangyuan Industrial Zone second Patentee after: Dongguan Shi Shi Shi Shi daily necessities Co., Ltd. Address before: Room 2118 building four layer d441 No. third Shanghai 201111 Minhang District Guanghua Road Patentee before: Shanghai Zhenxin Chemical Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170803 Address after: 523000 Guangdong city of Dongguan province Dongcheng District sangyuan Industrial Zone second Patentee after: Dongguan fortune daily necessities Co., Ltd. Address before: 523000 Guangdong city of Dongguan province Dongcheng District sangyuan Industrial Zone second Patentee before: Dongguan Shi Shi Shi Shi daily necessities Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150708 Termination date: 20171107 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |